No front page content has been created yet.
Dr. Mar Tintoré, new director of the Multiple Sclerosis Centre of Catalonia
Dr. Mar Tintoré Subirana is, as of October 1st, the new director of the Multiple Sclerosis Centre of Catalonia (Cemcat), taking over from Dr. Xavier Montalban.
With more than three decades of professional experience at the Vall d'Hebron University Hospital, Dr. Tintoré is also Head of Section of the Neurology Department and, until now, has served as Cemcat's Healthcare Director.
In the academic field, she is a professor at the University of Vic and associate professor at the Autonomous University of Barcelona. An internationally recognized leader, she served as president of ECTRIMS (2022-2024) and co-chair of its congress in Barcelona in 2025, which brought together over ten thousand MS experts. Currently, she is a member of the Clinical Trials Committee (ECTRIMS and NMSS) on diagnostic criteria for the disease, a member of the board of the European Charcot Foundation, and President of the Scientific Advisory Council of EME (Esclerosis Múltiple España).
Dr. Tintoré is also a principal investigator at VHIR and recognized, alongside other Cemcat members, as a highly cited author (1% Clarivate Highly Cited Authors), with over 360 original and review scientific publications. Her main research lines focus on therapeutic safety (infections and vaccination), care for elderly patients and vulnerable populations, early prognostic factors, improvement of diagnostic criteria, women's health and family planning, and pediatric multiple sclerosis.
Cemcat is part of the Vall d'Hebron Barcelona Hospital Campus. Created in 2007, it is a shared management project between the Catalan Health Institute, CatSalut, and the Multiple Sclerosis Foundation (FEM), integrating the public sector and civil society.
